Key Market Indicators
Israeli insulin imports are set to rise to nearly $30 million by 2026, according to a new report. The figure is currently estimated at $27 million for 2021, representing an average annual growth rate of 2%. Since 2000, Israeli demand for insulin has dropped by an average of 2.6% each year. In 2018, Israel exported $14,000 of insulin, a significant decrease from the $91,000 shipped in 2017. This put the country in 52nd place, behind Luxembourg, whose exports totalled $14,000. France, Italy and China took the top three positions in the ranking.
